Solution
Industries
Resources
About

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

Report Code: BIO074A

Publish Date: Oct 2010

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global CNS biomarker market was estimated at $1.3 billion in 2009 and is expected to reach close to $3.2 billion by 2015, with a compound annual growth rate (CAGR) of 17.1% from 2010 to 2015.
  • The CNS molecular diagnostic market will see the largest growth, with a compound annual growth rate (CAGR) of 172.3% from 2010 to 2015 due to the number of diagnostic tests that are in the pipeline. This sector is valued at $2 million in 2010 and is expected to be worth $302 million in 2015.
  • The growth rate for the CNS biomarker market for drug development will increase as more validated biomarkers become available for patient segmentation and assessment of efficacy for clinical trials. This sector is worth an estimated $162 million in 2010 and is expected to reach $355 million in 2015, a 17% compound annual growth rate (CAGR).

INTRODUCTION                                      

Biomarkers are measurable and quantifiable biological indicators that can be used to diagnose or predict disease, monitor disease progression, and predict treatment response.   They have played, and will continue to play, an important role in drug R&D and in diagnostics. They are important tools for understanding disease mechanism, developing more effective treatments, and improving the quality of patient care. The discovery of biomarkers for CNS disorders has gained considerable interest within the pharmaceutical industry due to the many unmet needs in current treatments and diagnostics.  
 
Here we examine the role of CNS biomarkers in early discovery, in drug development, and for future diagnostics. We assess the global CNS biomarker market and make forecasts from 2010 to 2015.   We further segment the market by application, technology (genomics, proteomics, and molecular imaging), and region.   We discuss the different disease segments, describing gaps in treatment and limitations of current methods of diagnosis. The process of developing biomarkers from discovery to commercialization is discussed along with the forces in the industry that play an integral role, such as payers, providers, and suppliers. We also address the growth drivers and growth inhibitors that can affect CNS biomarker adoption.  
 
STUDY GOALS AND OBJECTIVES
 
  • To assess the various technologies used for CNS biomarker discovery and future diagnostics.
  • To understand the process of CNS biomarker development from discovery to commercialization and the path towards adoption.
  • To examine the regulatory landscape and government’s role. 
  • To examine the unmet needs in diagnosis and treatment of various CNS disorders.
  • To determine current and future CNS biomarker markets.  
REASONS FOR DOING THE STUDY
 
This study was conducted to determine the current and future global demand for CNS biomarkers, taking into account various competitive forces, growth drivers, and growth barriers that are at play.  
 
SCOPE OF REPORT
 
This market research report:
 
  • Reviews technologies used to identify biomarkers for drug discovery, drug development, and diagnostic purposes specifically within the central ner­vous system (CNS) market
  • Analyzes global market trends, with data for 2009, estimates for 2010, and projections of compound annual growth rates through 2015
  • Evaluates technologies such as genomics, proteomics, and imaging, and weighs their advantages and disadvantages
  • Discusses CNS disease segments, prevalence, and gaps in treatment for Alzheimer’s disease, depression, Parkinson’s disease, multiple sclerosis, and others
  • Presents comprehensive company profiles and patent analyses.
INTENDED AUDIENCE
 
The study examines the current and future role of CNS biomarkers and their effect on various industries. Biotechnology companies, pharmaceutical companies, research institutions, physicians, hospitals, and manufacturers of genomic/proteomic supplies and technologies can all potentially benefit from strategic use of the market data and analysis contained in this report.   
 
INFORMATION SOURCES
 
BCC conducted primary and secondary market research to obtain market data for analysis and forecast projections. Interviews were conducted with experts in the industry, and data and information were compiled from government and public data sources, press releases, trade journals, publications, and selected databases.  
 
ANALYST’S CREDENTIALS
 
Munish Das is founder of BioEvolution LLC, a business research and consulting firm focused on healthcare. He has worked in the biotech and pharmaceutical industry for the past 10 years. He holds a master’s degree in biotechnology and business administration. 
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:  
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Central Nervous System (CNS) Biomarkers: Technologies and Global Markets148Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY2Free
Chapter- 3: OVERVIEW9Free
Chapter- 4: TECHNOLOGIES16Free
Chapter- 5: FACTORS INFLUENCING DEMAND OF BIOMARKERS9Free
Chapter- 6: GLOBAL REGULATORY ENVIRONMENT AND RECENT ECONOMIC CONDITIONS 7Free
Chapter- 7: CNS DISEASE SEGMENTS, PREVALENCE, AND GAPS IN TREATMENT17Free
Chapter- 8: GLOBAL CNS MARKET AND GROWTH2Free
Chapter- 9: MARKETS BY APPLICATION17Free
Chapter- 10: MARKET BY REGIONS9Free
Chapter- 11: MARKETS BY TECHNOLOGY3Free
Chapter- 12: MARKET BY CONDITION2Free
Chapter- 13: INDUSTRY STRUCTURE AND COMPETITIVE ANALYSIS11Free
Chapter- 14: PATENT INFORMATION12Free
Chapter- 15: C. CRAMER & CO. GMBH21Free
Chapter- 16: APPENDIX A4Free
Chapter- 17: APPENDIX B4Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 54

  • Summary Table: GLOBAL CNS BIOMARKER MARKET, BY APPLICATION, THROUGH 2015
  • Table 1: ADVANTAGES AND DISADVANTAGES OF EACH TECHNOLOGY FOR BIOMARKER STUDY
  • Table 2: REVENUES AND MARKET SHARE OF BIOMARKER DISCOVERY AND DRUG DEVELOPMENT SUPPLIERS, THROUGH Q1 2010
  • Table 3: NUMBER OF CASES OF CNS DISEASES FROM WHO, 2004
  • Table 4: NUMBER OF CASES OF CNS DISEASE, 2004
  • Table 5: ESTIMATED NUMBER OF CASES OF CNS DISEASE, 2008
  • Table 6: ESTIMATED NUMBER OF CASES OF CNS DISEASE, 2008
  • Table 7: MAJOR CNS COMPANIES, TREATMENTS, TOTAL MARKET, AND MARKET SHARE 2008
  • Table 8: GLOBAL CNS BIOMARKER MARKET BY APPLICATION, THROUGH 2015
  • Table 9: CNS DIAGNOSTIC COMPANIES AND DISEASE INDICATION
  • Table 10: NUMBER OF CNS DIAGNOSTIC BIOMARKERS IN DEVELOPMENT, BY INDICATION
Sample Report

Recent Reports

Biologic Therapies for Wound Care: Technologies and Global Markets

Published - Jun 2026 | Publisher - BCC Publishing | Code - BIO228B

The global market for wound care biologics is expected to grow from $7 billion in 2025 and is projected to reach $10.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2025 to 2030.

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Jun 2026 | Publisher - BCC Publishing | Code - BIO099G

The global market for single-use technologies (SUTs) for biopharmaceuticals was valued at $8.3 billion in 2025 and, is estimated to reach $9.2 billion by 2026 and $16.3 billion by 2031, at a compound annual growth rate (CAGR) of 12.2% from 2026 through 2031.

Cancer Profiling and Pathways: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - BIO073D

The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.

Global Markets for Protein Labeling

Published - May 2026 | Publisher - BCC Publishing | Code - BIO154B

The global market for protein labeling is expected to grow from $2.6 billion in 2025 and is projected to reach $4.3 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.

2025 DNA and RNA Synthesis Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - BIO265B

Discover the 2025 DNA and RNA Synthesis Research Review from BCC Research with insights into market developments, innovation trends and strategic opportunities.

Top Trending Reports

2025 Medical Devices Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - MDS060C

Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.

Cancer Profiling and Pathways: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - BIO073D

The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.

Validation, Calibration, and Standardization in the Life Sciences Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - BIO179B

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

Glass Fiber: Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - AVM225B

The global market for glass fiber is expected to grow from $13.5 billion in 2026 and is projected to reach $17.2 billion by the end of 2031, at a compound annual growth rate (CAGR) of 4.9% during the forecast period of 2026 to 2031.

2025 Chemical Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - CHM190B

BCC Research’s 2025 Chemical Research Review covering market trends, specialty chemicals, industrial innovation and growth opportunities across the chemical industry.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2026 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment